We're Not Very Worried About Helixmith's (KOSDAQ:084990) Cash Burn Rate
Mar 27
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Healthcare Sector Analysis
UpdatedApr 01, 2026
DataAggregated Company Financials
Companies373
- 7D-3.4%
- 3M-0.9%
- 1Y25.8%
- YTD-2.1%
Over the last 7 days, the Healthcare industry has risen 4.4%, driven by gains from Kolon TissueGene of 15%. In the same time, Sam Chun Dang Pharm was down 11%. This takes the industry's 12 month performance to a gain of 37%. As for the next few years, earnings are expected to grow by 38% per annum.
Sector Valuation and Performance
Has the South Korean Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 01 Apr 2026 | ₩365.7t | ₩65.5t | ₩1.6t | 17.6x | 231.8x | 5.6x |
| Fri, 27 Feb 2026 | ₩414.8t | ₩61.0t | ₩2.7t | 19.5x | 150.9x | 6.8x |
| Sun, 25 Jan 2026 | ₩379.1t | ₩61.0t | ₩2.7t | 18.8x | 140.4x | 6.2x |
| Tue, 23 Dec 2025 | ₩362.9t | ₩61.8t | ₩2.7t | 19.7x | 133.2x | 5.9x |
| Thu, 20 Nov 2025 | ₩344.0t | ₩60.5t | ₩2.2t | 19.2x | 158.9x | 5.7x |
| Sat, 18 Oct 2025 | ₩304.6t | ₩60.3t | ₩2.1t | 20.3x | 147.3x | 5x |
| Mon, 15 Sep 2025 | ₩307.7t | ₩60.0t | ₩1.9t | 21.7x | 159.4x | 5.1x |
| Wed, 13 Aug 2025 | ₩288.6t | ₩58.5t | ₩1.4t | 22x | 199.3x | 4.9x |
| Fri, 11 Jul 2025 | ₩294.0t | ₩57.9t | ₩1.5t | 21.6x | 196x | 5.1x |
| Sun, 08 Jun 2025 | ₩271.0t | ₩57.6t | ₩1.5t | 21.6x | 175.8x | 4.7x |
| Tue, 06 May 2025 | ₩270.8t | ₩56.1t | ₩1.4t | 18.6x | 198.6x | 4.8x |
| Thu, 03 Apr 2025 | ₩261.1t | ₩56.1t | ₩1.3t | 17.5x | 196.3x | 4.7x |
| Sat, 01 Mar 2025 | ₩280.1t | ₩54.9t | ₩867.6b | 14.5x | 322.8x | 5.1x |
| Mon, 27 Jan 2025 | ₩271.7t | ₩54.6t | ₩831.2b | 15.1x | 326.8x | 5x |
| Wed, 25 Dec 2024 | ₩253.0t | ₩54.4t | ₩802.1b | 13.9x | 315.4x | 4.7x |
| Fri, 22 Nov 2024 | ₩248.0t | ₩53.4t | ₩696.4b | 14.2x | 356.1x | 4.6x |
| Sun, 20 Oct 2024 | ₩282.2t | ₩53.3t | ₩854.8b | 17.5x | 330.1x | 5.3x |
| Tue, 17 Sep 2024 | ₩264.8t | ₩53.4t | ₩856.4b | 17.3x | 309.2x | 5x |
| Thu, 15 Aug 2024 | ₩257.5t | ₩52.2t | ₩703.0b | 16.4x | 366.2x | 4.9x |
| Sat, 13 Jul 2024 | ₩247.5t | ₩52.3t | ₩750.8b | 16.7x | 329.7x | 4.7x |
| Mon, 10 Jun 2024 | ₩231.9t | ₩52.9t | ₩737.3b | 16.3x | 314.6x | 4.4x |
| Wed, 08 May 2024 | ₩238.0t | ₩52.3t | ₩545.6b | 18.4x | 436.3x | 4.6x |
| Fri, 05 Apr 2024 | ₩234.1t | ₩52.3t | ₩463.2b | 17.6x | 505.3x | 4.5x |
| Sun, 03 Mar 2024 | ₩226.1t | ₩52.1t | -₩127,684,130,436.00 | 21.9x | -1770.6x | 4.3x |
| Tue, 30 Jan 2024 | ₩236.2t | ₩55.7t | ₩55.5b | 22.7x | 4258.4x | 4.2x |
| Thu, 28 Dec 2023 | ₩226.0t | ₩56.1t | ₩268.1b | 22.6x | 842.7x | 4x |
| Sat, 25 Nov 2023 | ₩209.6t | ₩56.1t | ₩388.0b | 19.5x | 540.2x | 3.7x |
| Mon, 23 Oct 2023 | ₩192.1t | ₩56.0t | ₩1.0t | 17x | 187.6x | 3.4x |
| Wed, 20 Sep 2023 | ₩216.3t | ₩56.0t | ₩941.3b | 20.1x | 229.8x | 3.9x |
| Fri, 18 Aug 2023 | ₩213.2t | ₩56.1t | ₩2.1t | 22.3x | 101.8x | 3.8x |
| Sun, 16 Jul 2023 | ₩206.9t | ₩56.1t | ₩2.1t | 21x | 98.3x | 3.7x |
| Tue, 13 Jun 2023 | ₩216.3t | ₩56.3t | ₩2.1t | 21.8x | 102.5x | 3.8x |
| Thu, 11 May 2023 | ₩214.6t | ₩58.4t | ₩3.3t | 21.4x | 65.8x | 3.7x |
| Sat, 08 Apr 2023 | ₩213.0t | ₩58.3t | ₩3.2t | 20x | 65.5x | 3.7x |
Price to Earnings Ratio
65.5x
Current Industry PE
- Investors are pessimistic on the South Korean Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 243x which is lower than its 3-year average PE of 284x.
- The 3-year average PS ratio of 4.7x is lower than the industry's current PS ratio of 5.9x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 21% per year over the last three years.
- Meanwhile revenues for these companies have grown 3.9% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare sector?
| KR Market | -8.74% | |
| Healthcare | -3.38% | |
| Healthcare Services | -1.21% | |
| Biotech | -2.73% | |
| Medical Equipment | -2.84% | |
| Healthtech | -2.94% | |
| Life Sciences | -3.92% | |
| Pharma | -4.38% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry even though it's trading below its 3-year average PE ratio of 83.5x.
- Analysts are expecting annual earnings growth of 22.4%, which is lower than the prior year's growth of 53.1% per year.
Forecasted Growth
- Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 61% over the next 5 years.
- This is better than its past earnings growth rate of 9.8% per year.
- In contrast, the Healthtech industry is expected to see its earnings decline by 38% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A950160 Kolon TissueGene | ₩106.70k | 14.7% +₩1.1t | 135.8% | PS1722x | |
| A086450 DongKook Pharmaceutical | ₩23.60k | 30.4% +₩248.1b | 56.1% | PE16.1x | |
| A084990 Helixmith | ₩8.32k | 43.2% +₩115.6b | 252.5% | PS147.5x | |
| A009420 Hanall Biopharma | ₩55.30k | 3.4% +₩91.4b | 98.9% | PS18.1x | |
| A028300 HLB | ₩50.60k | 1.2% +₩79.7b | -12.8% | PS83.3x |
